UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
MCDERMOTT INTERNATIONAL, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $1.00 PER SHARE
(Title of Class of Securities)
580037703
(CUSIP Number)
September 30, 2019
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed.
- Rule 13d-1(b)
- Rule 13d-1(c)
- Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 580037703 | SCHEDULE 13G | Page 2 of 11 | ||||
1 | NAME OF REPORTING PERSON OR | |||||
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | ||||||
Chatterjee Charitable Foundation | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) o | ||||
(b) o | ||||||
3 | SEC USE ONLY | |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | |||||
New York | ||||||
5 | SOLE VOTING POWER | |||||
0 | ||||||
NUMBER OF | 6 | SHARED VOTING POWER | ||||
SHARES | 600,000* | |||||
BENEFICIALLY OWNED | ||||||
BY EACH REPORTING | 7 | SOLE DISPOSITIVE POWER | ||||
PERSON | ||||||
WITH | 0 | |||||
8 | SHARED DISPOSITIVE POWER | |||||
600,000* | ||||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |||||
600,000* | ||||||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | o | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |||||
0.3%* | ||||||
12 | TYPE OF REPORTING PERSON | |||||
OO | ||||||
- See Item 4 for additional information.
CUSIP No. 580037703 | SCHEDULE 13G | Page 3 of 11 | ||||
1 | NAME OF REPORTING PERSON OR | |||||
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | ||||||
MCPI Holdings Limited | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) o | ||||
(b) o | ||||||
3 | SEC USE ONLY | |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | |||||
Mauritius | ||||||
5 | SOLE VOTING POWER | |||||
0 | ||||||
NUMBER OF | 6 | SHARED VOTING POWER | ||||
SHARES | 3,573,300* | |||||
BENEFICIALLY OWNED | ||||||
BY EACH REPORTING | 7 | SOLE DISPOSITIVE POWER | ||||
PERSON | ||||||
WITH | 0 | |||||
8 | SHARED DISPOSITIVE POWER | |||||
3,573,300* | ||||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |||||
3,573,300* | ||||||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | o | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |||||
2.0%* | ||||||
12 | TYPE OF REPORTING PERSON | |||||
FI | ||||||
- See Item 4 for additional information.
CUSIP No. 580037703 | SCHEDULE 13G | Page 4 of 11 | ||||
1 | NAME OF REPORTING PERSON OR | |||||
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | ||||||
Labvantage Solutions Technologies Limited | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) o | ||||
(b) o | ||||||
3 | SEC USE ONLY | |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | |||||
Mauritius | ||||||
5 | SOLE VOTING POWER | |||||
0 | ||||||
NUMBER OF | 6 | SHARED VOTING POWER | ||||
SHARES | 6,876,900* | |||||
BENEFICIALLY OWNED | ||||||
BY EACH REPORTING | 7 | SOLE DISPOSITIVE POWER | ||||
PERSON | ||||||
WITH | 0 | |||||
8 | SHARED DISPOSITIVE POWER | |||||
6,876,900* | ||||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |||||
6,876,900* | ||||||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | o | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |||||
3.8%* | ||||||
12 | TYPE OF REPORTING PERSON | |||||
FI | ||||||
- See Item 4 for additional information.
CUSIP No. 580037703 | SCHEDULE 13G | Page 5 of 11 | ||||
1 | NAME OF REPORTING PERSON OR | |||||
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON | ||||||
TCG Lifesciences Limited | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) o | ||||
(b) o | ||||||
3 | SEC USE ONLY | |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | |||||
Mauritius | ||||||
5 | SOLE VOTING POWER | |||||
0 | ||||||
NUMBER OF | 6 | SHARED VOTING POWER | ||||
SHARES | 6,876,900* | |||||
BENEFICIALLY OWNED | ||||||
BY EACH REPORTING | 7 | SOLE DISPOSITIVE POWER | ||||
PERSON | ||||||
WITH | 0 | |||||
8 | SHARED DISPOSITIVE POWER | |||||
6,876,900* | ||||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |||||
6,876,900* | ||||||
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | o | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |||||
3.8%* | ||||||
12 | TYPE OF REPORTING PERSON | |||||
FI | ||||||
- See Item 4 for additional information.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
McDermott International Inc. published this content on 04 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 October 2019 21:41:04 UTC